A recent estimate suggests roughly 70% of current lead compounds in modem d
rug discovery derive directly from the natural products, many of which are
glycosylated bacterial metabolites. Thus, bacterial glycosyltransferases an
d their corresponding sugar substrates contribute significantly to the dive
rsity of pharmaceutically important metabolites. This review summarizes (i)
the role that carbohydrates contribute to biologically active bacterial me
tabolites, (ii) a sequence homology classification of known glycosyltransfe
rases from these systems and (iii) the potential impact pathway engineering
and combinatorial biocatalysis may have on increasing carbohydrate-ligand
diversity. While the number of glycosylated bacterial metabolites is vast,
this review limits itself to glycosides with considerable published informa
tion pertaining to biological activity and biosynthesis.